|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2010 USD | -.--% |
|
-.--% | +66.12% |
| Market Cap | 1.55M 1.36M 1.25M 1.16M 2.19M 148M 2.24M 15.06M 5.85M 72.48M 5.81M 5.68M 252M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 934K 862K 797K 1.51M 102M 1.54M 10.36M 4.03M 49.89M 4M 3.91M 173M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 months | -28.21% | ||
| 6 months | +66.12% | ||
| Current year | +66.12% |
| Current year | 0.12 | 0.28 | |
| 1 year | 0.1 | 0.28 | |
| 3 years | 0 | 0.34 | |
| 5 years | 0 | 0.64 | |
| 10 years | 0 | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 2018-01-08 |
James Anderson
CEO | Chief Executive Officer | 56 | 2005-09-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 2005-12-31 |
James Anderson
BRD | Director/Board Member | 56 | 2006-11-30 |
Regina Anderson
CHM | Chairman | 79 | 2005-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-07-30 | Other | Director | 7,200 | 0.0888% | ||
| 24-07-30 | Other | Director | 5,600 | 0.0691% | ||
| 24-07-30 | Other | Director | 12,848 | 0.1585% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | +5.79% | -18.95% | 1.65M | ||
| -1.08% | +2.83% | +57.58% | +170.42% | 1,102B | ||
| -0.71% | +4.59% | +70.51% | +66.53% | 643B | ||
| -0.50% | +0.83% | +33.39% | +88.22% | 450B | ||
| -1.35% | +1.86% | +29.96% | +26.26% | 336B | ||
| -0.71% | +0.72% | +28.85% | +46.77% | 288B | ||
| -1.31% | -0.26% | -28.18% | -39.13% | 222B | ||
| +0.00% | +1.98% | +24.07% | +63.97% | 199B | ||
| -0.65% | +7.53% | +21.97% | +78.97% | 169B | ||
| +0.52% | +1.40% | -5.48% | -32.13% | 137B | ||
| Average | -0.61% | +2.03% | +23.85% | +45.09% | 354.51B | |
| Weighted average by Cap. | -0.85% | +2.07% | +40.53% | +86.18% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.11M 3.8M 3.51M 6.65M 449M 6.78M 45.62M 17.73M 220M 17.6M 17.21M 762M | 4.98M 4.37M 4.04M 3.73M 7.07M 477M 7.21M 48.52M 18.85M 234M 18.72M 18.31M 811M |
| Net income | -50.24K -44.07K -40.69K -37.6K -71.26K -4.81M -72.69K -489K -190K -2.35M -189K -185K -8.17M | -341K -299K -276K -255K -484K -32.66M -494K -3.32M -1.29M -15.98M -1.28M -1.25M -55.49M |
| Net Debt | -427K -375K -346K -320K -606K -40.93M -618K -4.16M -1.62M -20.03M -1.61M -1.57M -69.53M | -482K -423K -390K -361K -684K -46.16M -697K -4.69M -1.82M -22.59M -1.81M -1.77M -78.42M |
Employees
20
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
















